Market Research Logo

Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review

Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review

Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bioxyne Ltd (Bioxyne), is a biotechnology company that develops, manufactures, markets and commercializes healthcare products in the areas of immune health and immunotherapeutics. It manufactures consumer food supplements such as, ProTract and Progastrim, which are based on a proprietary probiotic strain PCC (lactobacillus fermentum). It also develops a range of existing functional food and beauty products containing ingredients sourced from New Zealand. The company caters to consumer dietary supplements and functional foods markets. Its products are used as dietary supplement and foodstuffs and beverages. The company has manufacturing and distribution agreements with Chr. Hansen and Nu-Skin Enterprises. The company distributes its products across North America and Europe. Bioxyne is headquartered in Sydney, New South Wales, Australia.

Bioxyne Ltd Key Recent Developments

Oct 29,2018: Bioxyne: Quarterly report for the period ended 30 September 2018
Jul 27,2018: Bioxyne: Quarterly report for the period ended 30 June 2018
May 01,2018: Bioxyne: Non-Executive Director Appointment – Peter Charles Hughes-Hallett
Apr 27,2018: Bioxyne: Quarterly Report for the Period ended 31 March 2018
Feb 15,2018: Bioxyne: Resignation of Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Bioxyne Ltd - Key Facts
Bioxyne Ltd - Key Employees
Bioxyne Ltd - Key Employee Biographies
Bioxyne Ltd - Major Products and Services
Bioxyne Ltd - History
Bioxyne Ltd - Company Statement
Bioxyne Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Bioxyne Ltd - Business Description
Bioxyne Ltd - SWOT Analysis
SWOT Analysis - Overview
Bioxyne Ltd - Strengths
Bioxyne Ltd - Weaknesses
Bioxyne Ltd - Opportunities
Bioxyne Ltd - Threats
Bioxyne Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Bioxyne Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 29, 2018: Bioxyne: Quarterly report for the period ended 30 September 2018
Jul 27, 2018: Bioxyne: Quarterly report for the period ended 30 June 2018
May 01, 2018: Bioxyne: Non-Executive Director Appointment – Peter Charles Hughes-Hallett
Apr 27, 2018: Bioxyne: Quarterly Report for the Period ended 31 March 2018
Feb 15, 2018: Bioxyne: Resignation of Director
Dec 11, 2017: Positive Bioxyne Gut Health Clinical Trial Results
Jul 31, 2017: Bioxyne: Quarterly Report for the Period Ended 30 June 2017
Apr 27, 2017: Bioxyne: Quarterly Report for the Period Ended 31 March 2017
Feb 27, 2017: Bioxyne: Interim Financial Report For the Half Year ended 31 December 2016
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Bioxyne Ltd, Key Facts
Bioxyne Ltd, Key Employees
Bioxyne Ltd, Key Employee Biographies
Bioxyne Ltd, Major Products and Services
Bioxyne Ltd, History
Bioxyne Ltd, Subsidiaries
Bioxyne Ltd, Key Competitors
Bioxyne Ltd, Annual Ratios
Bioxyne Ltd, Annual Ratios (Cont...1)
Bioxyne Ltd, Annual Ratios (Cont...2)
Bioxyne Ltd, Interim Ratios
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Bioxyne Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Bioxyne Ltd, Performance Chart (2014 - 2018)
Bioxyne Ltd, Ratio Charts
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report